Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma
- PMID: 17151787
- PMCID: PMC7102208
- DOI: 10.1245/s10434-006-9217-3
Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma
Abstract
Purpose: To identify the prognostic factors for pulmonary metastasectomy (PM-ectomy) in hepatocellular carcinoma (HCC).
Patients and methods: We conducted a retrospective review of patients with pulmonary metastases (PM) from HCC who had undergone curative PM-ectomy at National Taiwan University Hospital between 1990 and 2004. Univariate (log-rank) and multivariate (Cox's model) analyses of survival were used to identify the significant prognostic factors.
Results: In total, 34 patients were eligible for curative PM-ectomy. The overall survival rates (Kaplan-Meier) after PM-ectomy were 65.2% and 27.5% at 2 and 5 years, respectively. High alpha-fetoprotein level, positive hepatic resection margin, and short disease-free interval (DFI) were unfavorable factors for overall survival from univariate analysis, however, only DFI (P = 0.028) was identified as an independently prognostic factor by multivariate analysis. Bilateral distribution and more PMs were unfavorable factors for PM-free survival from univariate analysis, with only PM number identified as an independent prognostic factor by multivariate analysis (P = 0.017).
Conclusion: Patients with longer DFIs and fewer PMs can benefit from PM-ectomy in HCC.
Figures
References
-
- Utsunomiya T, Shimada M, Shirabe K, et al. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma. Hepato-Gastroenterology. 2001;48(40):1088–1093. - PubMed
-
- O’Suilleabhain CB, Poon RT, Lau CW, Fan ST. Repeated resections of extrahepatic metastases after hepatic resection: an aggressive approach to hepatocellular carcinoma. Hepatogastroenterology. 2004;51(57):82582–9. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
